Bhat Laxminarayan
SEC insider (Form 3/4/5 filer). CIK 0001818245. President and CEO at REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH). 6 reported Form 4/5 transactions since Sep 2024; latest on Mar 18, 2026. Located in CUPERTINO, CA.
Companies Bhat Laxminarayan has filed insider reports for
- REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH): Director, Officer, President and CEO
Bhat Laxminarayan
CIK: 0001818245
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
REVIVA PHARMACEUTICALS HOLDINGS, INC.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Mar 18, 2026RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
AwardDirectStock Option (right to buy)
109.2K shares- - Mar 18, 2026RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
AwardIndirectStock Option (right to buy)
40.9K shares- - Feb 13, 2025RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
AwardDirectStock Option (right to buy)
519K shares- - Feb 13, 2025RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
AwardIndirectStock Option (right to buy)
181.5K shares- - Sep 15, 2024RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
AwardDirectStock Option (right to buy)
158.5K shares- - Sep 15, 2024RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
AwardIndirectStock Option (right to buy)
77.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 18, 2026 | RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. | Award Stock Option (right to buy) | 109,150 | - | - | Direct |
| Mar 18, 2026 | RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. | Award Stock Option (right to buy) | 40,925 | - | - | Indirect |
| Feb 13, 2025 | RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. | Award Stock Option (right to buy) | 519,000 | - | - | Direct |
| Feb 13, 2025 | RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. | Award Stock Option (right to buy) | 181,500 | - | - | Indirect |
| Sep 15, 2024 | RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. | Award Stock Option (right to buy) | 158,451 | - | - | Direct |
| Sep 15, 2024 | RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. | Award Stock Option (right to buy) | 77,843 | - | - | Indirect |
1-6 of 6 transactions